1 Min Read
Nov 21 (Reuters) -
* U.S. FDA accepts regulatory submission and grants priority review for US Worldmeds’ Lofexidine
* US Worldmeds - U.S. FDA has accepted and granted priority review of New Drug Application for Lofexidine Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.